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Abstract
Background: There is a need for simple tools such as the M.tuberculosis specific IFN-c release assays (IGRA) to improve
diagnosis of M.tuberculosis-infection in children. The aim of the study was to evaluate the performance of an IP-10 and IL-2
based tests for the diagnosis of M.tuberculosis-infection in recently exposed children from Nigeria.
Methodology and Principal Findings: Samples were obtained from 59 children at high risk of infection with M.tuberculosis
(contacts of adults with smear and culture-positive tuberculosis) and 61 at low risk (contacts of smear-negative/culture-
positive tuberculosis or community controls). IP-10 and IL-2 was measured in plasma after stimulation of whole-blood with
M.tuberculosis specific antigens and mitogen. Previously developed criteria for positive IP-10 and IL-2 tests were used and
the diagnostic performances of the IP-10 and IL-2 tests were compared with the Quantiferon In-Tube (QFT-IT) and the
Tuberculin Skin Tests (TST). In response to M.tuberculosis specific antigens, the high-risk children expressed significantly
higher levels of IP-10 (1358 pg/ml[IQR 278–2535 pg/ml]) and IL-2 (164 pg/ml[11–590 pg/ml]) than low risk groups 149 pg/
ml(25–497 pg/ml), and 0 pg/ml(0–3 pg/ml), respectively. There was excellent agreement (.89%,k.0.80) between IP-10, IL-
2 tests and QFT-IT, better than with TST (.74%,k.0.49). The IP-10 and IL-2 responses were strongly associated with
M.tuberculosis exposure and with grade of infectiousness of the index cases (p,0.0001). IP-10, IL-2, and TST but not QFT-IT
was associated with age of the child in the low risk groups (p,0.02).
Conclusions/Significance: IP-10 is expressed in high levels and results of the IP-10 test were comparable to the QFT-IT. IL-2
was released in low amounts in response to the antigens and not in response to the mitogen therefore IL-2 seems a less
useful marker. We have demonstrated that IP-10 and possibly IL-2 could be alternative or adjunct markers to IFN-c in the
diagnosis infection with M.tuberculosis.
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Introduction
Tuberculosis (TB) in children has long been neglected. The new
WHO Stop TB Strategy, launched in 2006, aims at ensuring
access to diagnosis and treatment of TB according to international
standards, regardless of age[1]. Children recently exposed are at
high risk of developing active disease. Preventive chemotherapy is
effective, but is rarely used in high endemic regions despite WHO
recommendations. This is due to the limited resources available,
fear of emerging drug resistance and the lack of adequate tools for
detection of infection in children. A major challenge for the wider
implementation of targeted prophylaxis is the development of
simple diagnostic tests for infection with M.tuberculosis (Mtb.).
With the identification of three Mtb. specific protein antigens
(ESAT–6, CFP10, and TB 7.7), new diagnostic tests have emerged
[2,3]. These tests measure interferon gamma (IFN-c) release after
the stimulation of whole-blood (QuantiferonH –TB-Gold In Tube
test (QFT-IT) (Cellestis Australia) or purified mononuclear cells
(T-SPOT-TBH) (Oxford Immunotech) with the antigens and are
known as Interferon Gamma Release Assays (IGRA). The
antigens are contained within the RD1 and RD13 regions of the
mycobacterial genome, which are absent from M. bovis Bacille
Calmette Guerin (BCG), M. avium and most other non–
tuberculosis mycobacteria [2,4]
Although these tests are sensitive and specific for the detection
of infection with Mtb. [3,5–11], several reports suggest that their
PLoS ONE | www.plosone.org 1 August 2008 | Volume 3 | Issue 8 | e2858sensitivity may be lower in patients with active TB[3,12,13], that
patients with HIV and severe immunosuppression may have an
increased proportion of indeterminate results[12,14–16], but there
are only few studies including children.
Other biomarkers, alone or in combination, could enhance the
diagnostic performance of IGRAs and we have previously
reported that the IFN-c-inducible protein 10 (IP-10) and
(monocyte chemotactic protein-2 (MCP-2), and the interleuki-
n(IL)-2 could be alternative or adjunct biomarkers to IFN-c [17]
IFN-c-inducible protein 10 has been designated the 10
th
member of the CXC-chemokine family, CXCL10. It is predom-
inantly produced by cells of the monocyte/macrophage lineage
and is involved in trafficking monocytes and activated Th1 cells to
inflamed foci through interaction with the CXCR3 chemokine
receptor[18,19]. High levels of IP-10 are found in the lymph nodes
and tuberculous granulomas[20], in pleural effusions and
broncoalveolar lavage [21,22], in the serum of TB and TB-HIV
co-infected patients experiencing the immune reconstitution
syndrome[23,24] and in PPD challenge of blood mononuclear
and bronchoalveolar cells[24,25]. IL-2 promotes T cell replication
and is essential for cellular immunity and granuloma formation.
Mtb antigen-dependent IL-2 production has been demonstrated in
patients with active TB[26] and its serum concentrations are
elevated in patients with active TB, returning to normal with
treatment[27].
We have recently shown that QFT-IT has the potential to
detect Mtb infection in recently exposed children from Nigeria in
line with TST. We recently demonstrated a trend of increasing
TST and QFT-IT responders with increasing numbers of bacilli in
sputum of the index case [8] - a relationship which has been
reported for the TST in other studies [28,29]. The present study
evaluated the potential performance of IP-10 and IL-2 as
alternative or adjunct markers of Mtb. infection. In this setting
we used the infectiousness of the index case to determinate the risk
of infection of the child.
Materials and Methods
Objectives
The aim of the study was to evaluate the performance of
previously defined IP-10 and IL-2 based tests for the diagnosis of
tuberculosis-infection in recently exposed children from Nigeria.
Participants
Study setup. Children were included as part of a study
evaluating the risk of infection among children in contact with
adults with culture positive pulmonary TB in Nigeria as described
in [30].Children living in the households with adults who were
diagnosed with culture positive TB were enrolled. Home visits
were conducted between March and May 2005 .12 weeks after
diagnosis of the index case. Eligible children were defined as any
relative in the household ,15 years of age who ate food prepared
in the same cooking facilities as the index patient. During a home
visit, a list of the children in the family was obtained, and ,5o f
these children were selected randomly to participate in the study.
A thorough description of the recruitment and classification of the
initial study population has been published [30] Culture was
performed using BACTEC culture (Becton Dickinson, Sparks,
MD, USA) by trained staff at Zankli TB Research Laboratory in
Abuja. Results of the smear microscopy (bacillary load) of the
adults were recorded according to the International Union Against
Tuberculosis and Lung Diseases grading system as negative,
scanty, +, ++ and +++ acid fast bacilli. Since all adults enrolled in
the study had positive cultures, they were classified as having
sputum smear-positive or sputum smear-negative TB Children
were included .12 weeks after the index case was diagnosed and
started on chemotherapy. We assumed that all infected would
have developed Mtb specific immunity and we assumed that no
further exposure took place although resistance testing was not
done. Children included from a household of a sputum smear
positive or negative adults were termed ‘‘SS+ contact’’ and ‘‘SS–
contacts’’ respectively.
A group of children living in households with no known
exposure to adults with active TB was included as community
controls (CC). The HIV status of the adults was assessed as part of
the routine investigations for TB (ImmunoComb HIVI and HIVII
BiSpot kit (ORGENICS, Yavne, Israel)). Fifty (83%) of the adults
were HIV1/2 tested and 28 (56%) were HIV-1 positive; none were
HIV-2 positive. The HIV-status of the children was not known.
The parents were interviewed using a questionnaire including
medical history, degree of contact and clinical data including
weight, height, and signs of active TB. Children with symptoms
compatible with TB were referred to hospitals for further
assessment and treatment. Chemoprophylaxis is not routinely
offered in Nigeria, neither to children nor to HIV positive adults
and was not given as part of this study. The incidence of TB in
Nigeria is estimated to be 293/100.000[31], the prevalence of
HIV-1 infection is estimated to be 6% of the adult population and
27% of the adults with TB are co-infected with HIV (.98% HIV-
1) [32]. BCG-vaccination is routinely given at birth.
Blood sampling and biomarker measurement. From all
children 361 ml of blood was drawn into vacutainer tubes coated
with either saline (negative control tube), ESAT-6, CFP-10, and
TB 7.7 peptides (M. tuberculosis–specific antigen tube), or the
mitogen, phytohemaglutinin (PHA) (positive control tube). Tubes
were transported to the laboratory in Abuja 2–6 hours after
collection, and incubated overnight at 37uC. The tubes were then
centrifuged, and the supernatant plasma was harvested and stored
at 280uC. Later samples were transported to Hvidovre Hospital in
Copenhagen on dry ice, and stored at 280uC. Samples were
tested by ELISA for IFN-c in 2006[8]. In 2007 supernatants were
thawn and analysed by xMAP.
During the initial study[30] there was a shortage of mitogen
tubes, and 79 of the 207 children enrolled were not tested with
mitogen. For the present analysis, only samples where mitogen
results were available were included. Thus for the present study,
128 of the 207 children initially screened with QFT-IT were
evaluated for the presence of IP-10 and IL-2. There was no
selection of who would be tested with mitogen as children were
enrolled consecutively until stocks of mitogen tubes ran out. There
were no significant age, sex, TST or QFT-IT differences between
the children 128 included here and those not included.
Description of procedures or investigations undertaken
Tuberculin skin test (TST). Children were tested using the
Mantoux method and 10 Units PPD (ChironVaccines Evans,
Liverpool UK) equivalent to 5 IU tuberculin. TST readings were
obtained by using the palpation method 48–72 hours later[8].
Induration $10 mm was used as cut off for positive result, and
results using .5 mm and .15 mm were also calculated.
IFN-c determination by Quantiferon. The QFT-IT test
was performed according to the manufacturer’s instructions as
described previously[30]. Results are shown in pg/ml to facilitate
comparisons with other biomarkers. One International Unit (IU)
of IFN-c corresponds to 50 pg/ml (NIBSC, Hertfordshire, UK).
After subtracting the value from the negative control, the result
was positive if, the antigen-dependent response was $0.35
IU(17.5 pg/ml), negative if the mitogen–induced response was
IP-10 as a Biomarker for LTBI
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,0.35 IU/ml(17.5 pg/ml), and indeterminate if both mitogen-
induced and antigen-dependent responses were below cut-off or
mitogen-induced response .8 IU/ml (400 pg/ml).
IP-10, IL-2 and IFN-c determination by xMAP and criteria
for the diagnostic tests
IP-10, IL-2 and IFN-c were measured by xMAP technology on
the Luminex platform (Luminex Corporation), using Biosource
reagents (Biosource Camarillo USA) acquired and analyzed with
the STarStation v2.0 software (Applied Cytometry Systems) as
previously described [17]. All measurements were performed in
duplicate and blinded. The upper limits of quantification of
cytokines using xMAP were 2,800 pg/ml for IP-10, 12,264 pg/ml
for IL-2 and 27,200 pg/ml for IFN-c. Cytokine concentrations
above the limit of quantification were assigned the upper limit.
The children were classified as positive, negative and indetermi-
nate IP-10 test responders according to a test algorithm developed
previously (Ruhwald et al, submitted). An IP-10 test was defined
positive if: the antigen-dependent response was $455 pg/ml,
negative if ,455 pg/ml and the mitogen-induced response was
$200 pg/ml, and indeterminate if both antigen-dependent and
mitogen-induced responses were below cut off. IL-2 test algorithm
was previously defined using 13 pg/ml as cut off [15]. An IL-2 test
was defined positive if: the antigen-dependent response was
$13 pg/ml and at least 125% of the nil value. (Details on the
IP-10 and IL-2 test algorithms are provided in supporting
information Methods S1).
Ethics
The study was initiated and led by researchers from the School
of Tropical Medicine and the University of Liverpool, both in
Liverpool, UK in collaboration with Zankli Medical Centre in
Abuja, Nigeria. Ethical approval for the study protocol, including
permission to tests for IL-2 and IP-10, as described here, were
obtained from the Institutional Review Board of these centres.
Statistical methods
Data were analysed using SAS 9.1.3 (SAS institute). Variables
with normal distributions were described using means and
standard deviations and means were compared using Student’s
t-test. Median TST readings and biomarker responses were
compared using non-parametic tests (Kruskal-Wallis, Wilcoxon
rank sum test). ELISA and xMAP IFN-c measurements were
correlated using Spearman’s rank test. The antigen-dependent and
mitogen-specific biomarker production was measured by subtract-
ing the concentration measured in the un-stimulated tube from the
concentration measured in the antigen and mitogen tubes.
The concordance between TST, QFT-IT, IP-10, and IL-2 tests
was assessed using Kappa statistics and McNemar’s test. The
Cochran-Armitage test for trend was used to correlate the
prevalence of positive responders to the sputum smear grade of
the index case and age. Fisher’s exact test was used to compare
differences in proportion of test-responders within groups. All tests
were two sided and p values ,0.05 were considered significant.
Results
Samples from 128 children were tested for the presence of IP-10
and IL-2. Of these, 8 were excluded from analysis due to technical
errors in the xMAP analysis (coefficient of variation .20% on
more than 4 of the 9 set of measurements (n=3) or lab handling
errors (n=5)). A total of 120 children had valid results and were
included in the analysis. Fifty-nine (49%) children had been in
contact with adults with SS+ TB, 38 (32%) with adults with SS2
TB, and 23 (19%) were community controls, age and sex
distribution is presented in table 1.
Comparing IFN-c levels measured by xMAP or ELISA
The correlation between IFN-c concentrations measured using
QFT-IT ELISA and xMAP in samples stimulated with with Mtb-
specific antigens and mitogen was very strong (r=0.79 and 0.85,
p,0.0001). There was no correlation in un-stimulated samples
(r=0.17, p=0.07) as they were all very low. IFN-c concentrations
measured by xMAP were 3.5 fold (Inter quartile range 1.5–10)
lower than ELISA concentrations (p,0.0001). Because of these
low levels of IFN-c measured by the xMAP we concluded that
xMAP determination of IFN-c would be too uncertain and we
decided only to use IFN-c measurements based on the QFT-IT
ELISA for the subsequent analysis.
Antigen-dependent IL-2, IP-10 and IFN-c responses were
associated with Mtb exposure
Upon stimulation with Mtb-specific antigens, SS+ contacts
released significantly higher concentrations of the three biomark-
ers than SS2 contacts and CC (p,0.0001) did and there was no
significant difference between SS2 contacts and CC (p.0.4)
(table 2 and figure 1). Median levels of IP-10 and IFN-c after
mitogen stimulation were 422 pg/ml (IQR 278–909 pg/ml) and
158 pg/ml (53–532 pg/ml) respectively, whereas the median level
of mitogen-induced IL-2 was very low 5 pg/ml (0–254 pg/ml).
There were no significant differences in the mitogen-induced levels
of IP-10 and IFN-c between the three groups (p.0.1), but the level
of mitogen-induced IL-2 was higher in the SS+ group compared
with the low risk groups (p,0.5). In un-stimulated samples, the
concentrations of the three biomarkers were low and comparable
between the groups (p.0.09).
Identifying children at risk of LTBI using the QFT-IT, IP-10,
IL-2 and TST
All four tests identified a significantly higher percentage of
positive responders within the group of children exposed to
sputum smear positive adults (table 3). Results obtained using
QFT-IT was comparable to those obtained by the IL-2 and IP-10
tests. Among SS2 contacts we found less QFT-IT responders
compared to the IP-10 test (p,0.03, McNemar).
QFT-IT was indeterminate in 19 cases (16%), 14 were due to
low mitogen responses and 5 due to a high nil response. There was
no association with history of BCG vaccination and test results for
any of the biomarkers or TST p.0.25). We were not able to
demonstrate a difference in proportion of positive or indetermi-
Table 1. Demographic data: number of children included,
age, sex distribution and history of BCG vaccination stratified
by exposure risk group.
SS+ SS2 CC
N, (% of total) 59 (49) 38 (32) 23 (19)
Age (mean years (s.d.)) 8.5 (3.5) 8.8 (3.9) 7.7 (3.7)
Under 5 y old, n(%) 8 (14) 7 (18) 5 (22)
Male sex (n (%)) 23 (39) 16 (42) 12 (52)
BCG vaccinated n (%) 50 (85) 32 (84) 21 (91)
There were no significant differences between the groups.
doi:10.1371/journal.pone.0002858.t001
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(p.0.3). Diagnostic properties of the biomarkers independent of
cut points are presented in Supporting Information Figure S1.
Concordance between tests
The agreement between the QFT-IT and the IP-10 test results
was very high (93/120, 78%, k=0.64) and after excluding
indeterminate responders the agreement between QFT-IT and
IP-10 increased to 93/102, 89%, k=0.80. (Table 4 and Table 5).
The agreement between the QFT-IT test and the IL-2 test after
excluding QFT-IT indeterminate tests 96% (97/101, k=0.92).
The agreement with the TST (.10 mm) and the biomarker tests
were as follows: IP-10 test (69/93, 74%, k=0.49), IL-2 test (88/
111, 79%, k=0.57), and the QFT-IT (70/93, 75%, k=0.50). The
concordance between the different tests is presented in supporting
information Table S1 and Table S2.
Association between Mtb. exposure and age with test
results
The proportion of children with positive tests stratified by the
sputum smear grade of the index case was calculated (Figure 2).
There was a significant trend for increasing test positivity rate by
increasing smear grade among the TB contacts for all biomarkers
(p,0.0001, Cochran-Armitage test for trend). The exclusion of
indeterminate responders had no influence on the strength of the
association. Using alternative cut points between 237 and 673 pg/
ml for the IP-10 test did not change this strong association (data
not shown),
It is well known that the risk of infection increases with age
based on TST studies[28,29] and we tested if there was a trend in
test positivity rate with increasing age among the children. As all
our results indicate that children of SS2 adults appear to have a
low risk of household exposure comparable to the CC, we pooled
these two groups for the sub-analysis (n=61). The SS2 and CC
did not differ significantly with respect to demographic data,
antigen-dependent - and mitogen-specific biomarker levels, or test
results. Figure 3 depicts the proportion of positive test responders
by age groups. There was a significant age associated increase in
rate of positive responders for the IP-10 test (p=0.01), the IL-2
(p=0.02) test, and the TST (10 mm) (p,0.004), but not for the
QFT-IT (p=0.22). When excluding indeterminate responders,
this trend increased in strength and significance for the IP-10 test
(p=0.005), but there was still no trend observed for QFT-IT
(p=0.17). In contrast, there was no association between age and
test positivity in the high risk group (SS+ contacts) for any of the
biomarkers and TST (at 10 mm) (p.0.3)
Combining biomarkers
We have previously demonstrated that a combined biomarker
approach, classifying a responder positive if either the IP-10 test or
the QFT-IT was positive, increased the sensitivity for diagnosing
active tuberculosis (Ruhwald et al submitted). Using this combined
biomarker approach, the rate of positive responders in SS+,S S 2
and CC groups were 45/59 (76%), 3/38 (21%) and 6/23 (26%)
respectively, and the rate of indeterminate responders decreased to
2/59 (3%), 4/38 (11%) and 4/23 (17%) (table 6). Among SS2 and
SS+ the proportions of positive responders using the combined
approach were significantly higher compared to QFT-IT alone
(p,0.03 and p,0.05) and among SS2 the rate of indeterminate
results was significantly lower when compared to the IP-10 test
(p,0.03). There were no significant increases in the rate of positive
responders when combining the IL-2 test with the IP-10 test
(p.0.3), or the QFT-IT test (p.0.08) (data not shown).
Discussion
The study compares the performance of IP-10 and IL-2 with
TST and QFT-IT for the diagnosis of Mtb. infection in children
recently exposed to infectious cases of TB in a high endemic
setting. The main findings are that a) IP-10 and IL-2 are expressed
in high amounts in response to Mtb.specific antigens, b) The IP-10
test performs with excellent concordance and to the QFT-IT test
and the agreement between the IP-10 and QFT-IT was stronger
than with the TST, and c) The IP-10 and IL-2 responses were
strongly associated with TB exposure as determined by exposure
risk groups, by grade of infectiousness of the index cases, and by
age of the child with low risk and d) combination of IFN-c and IP-
Table 2. Production of IP-10, IL-2 and IFN-c in un-stimulated, antigen-dependent, and mitogen-induced whole-blood from
children exposed to sputum smear and culture positive adults (SS+), sputum smear negative but culture positive (SS2) adults, or
community controls (CC).
SS+ (n=59) SS2 (n=38) CC (n=23)
IP-10 Un-stimulated 106 (61–185) 143 (72–310) 126 (55–213)
Antigen-dependent 1358 (278–2535)
a,b 117 (32–341) 149 (25–497)
Mitogen-induced 445 (250–708) 400 (231–983) 466 (105–934)
IL-2 Un-stimulated 1 (1–2) 1 (1–3) 1 (1–2)
Antigen-dependent 164 (11–590)
a,b 0 (0–5) 0 (0–3)
Mitogen-induced 14 (5–21)
c,d 3 (1–31) 5 (1–14)
IFN-c (ELISA) Un-stimulated 12 (9–29)
d 24 (14–52) 17 (11–38)
Antigen-dependent 106 (16–585)
a,b 1 (0–3) 0 (0–6)
Mitogen-induced 207 (63–449) 172 (50–289) 87 (17–433)
IFN-c (xMAP) Un-stimulated 1 (1–2) 1 (1–6) 1 (1–4)
Antigen-dependent 54 (4–309)
a,b 2 (0–7) 0 (0–8)
Mitogen-induced 117 (44–227) 70 (17–181) 53 (13–127)
Data are shown as median concentrations in pg/ml,(25 and 75 percentile). Significant differences were found when comparing SS+ and CC (p,0.0001
a and p,0.05
d),
and when comparing SS+ and SS2 (p,0.0001
b and p,0.03
c).
doi:10.1371/journal.pone.0002858.t002
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Test result QFT-IT IP-10 test IL-2 test TST 5 mm TST 10 mm TST 15 mm
n/n total (%) n/n total (%) n/n total (%) n/n total (%) n/n total (%) n/n total (%)
SS+ contacts, Positive 42/59 (71) 42/59 (71) 44/59 (75) 36/53 (68) 24/53 (47)
a 6/53 (11)
b
Negative 11/59 (19) 13/59 (22) 15/59 (25) 17/53 (32) 31/53 (53) 47/53 (89)
Indeterminate 6/59 (10) 4/59 (7) - - - -
SS2 contacts, n/n total (%) Positive 3/38 (8)
a 8/38 (21) 7/38 (18) 16/37 (43)
a 7/37 (19) 1/37 (3)
b
Negative 28/38 (74) 21/38 (55) 31/38 (82) 21/37 (57) 30/37 (81) 36/37 (97)
Indeterminate 7/38 (18) 9/38 (24) - - - -
Controls, n/n total (%) Positive 3/23 (13) 6/23 (26) 4/23 (17) 6/21 (29) 2/21 (10) 0/21 (0)
Negative 14/23 (61) 12/23 (52) 19/23 (83) 15/21 (71) 19/21 (90) 21/21 (100)
Indeterminate 6/23 (26) 5/23 (22) - - - -
aSignificantly different proportions of positive responders compared with the IP-10 test: p,0.03
bSignificantly different proportion of positive responders compared
with the IP-10 test: p,0.009.
doi:10.1371/journal.pone.0002858.t003
Figure 1. RD1 antigen dependent biomarker release in children with high and low risk of TB infection. Whole-blood from 59 contacts to
a sputum smear-positive household adult (SS+), 38 contacts to a sputum smear-negative culture-positive adult (SS2), and 23 community controls
(CC) was stimulated with RD1 antigens. Individual Interferon (IFN)-c, IFN-c-inducible protein (IP)-10, and Interleukin (IL)-2, responses after stimulation
are shown (the values of the un-stimulated wells have been subtracted). Each dot indicate an individual response, horizontal lines indicate median.
doi:10.1371/journal.pone.0002858.g001
IP-10 as a Biomarker for LTBI
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or SS+ group and there were fewer indeterminate results.
Childhood tuberculosis has long been neglected, but there is
now focus on improving the diagnosis of active TB, and an
increasing awareness of the use of prevention. WHO emphasizes
that exposed children ,5 years and HIV positive should be
offered chemo-prophylaxis. However, blind prescription of
Isoniazid may result in poor compliance and rapid development
of resistance. Therefore targeted treatment of the infected
subgroups would be a more rational approach than mass
treatment. TST has been the only tool for the identification of
infection in recently exposed children but it suffers from several
operational and performance constrains such as low specificity,
subjectivity in readout, dual visits, risk of boosting etc. A qualified
alternative to the TST are the IGRAs using the RD1 antigens
specific to M.tb[3], and we have recently shown that the QFT-IT
was strongly associated with risk of recent exposure among
children 1–14 years old in Nigeria[33]. Thus with tests based on
RD1 peptides, targeted chemo-prophylaxis may become a realistic
option even in high endemic countries.
As part of our search for improved and simple diagnostic
measures we have compared the performance of IP-10 and IL-2
with QFT-IT in a diagnostic setting without a gold standard for
infection, we used predefined cut offs and criteria for positive test
results and exposure gradient as indicators for infection. We found
that children 1–14 years old produced IP-10 and IL-2 in significant
amountsafterantigen-stimulationandwefoundastrongcorrelation
between the biomarkers and risk of infection. Of the high risk
children 71–75% were positive by IP-10 and IL-2 indicating a high
sensitivity of a potential test based on IL-2 or IP-10.
The agreement between IGRA and TST varies between studies
and ranges from excellent to poor[3]. There are several
explanations for this discordance such as prevalence of TB, prior
BCG, age at BCG vaccination, strain of BCG and batch of
Tuberculin, age, co-morbidity etc. This matter has been
intensively debated but there is consensus that the IGRAs are
more specific for Mtb. infection, not influenced by prior BCG or
exposure to NTM, and less affected by immuno-suppression[3].
Using the QFT-IT, as the comparator, we found excellent
agreement between both the IP-10 and the IL-2 test. Although
the performance of TST was good in this study the agreement
with the TST and QFT-IT or IP-10 test was low, a finding which
is consistent with other studies comparing TST and IGRA in high
prevalence countries [34,35]. In our previous study using exactly
same IP-10 cut off and diagnostic algorithm, the positivity rate was
89% for patients with active TB and 3% for healthy unexposed
students and we found 89% agreement between IP-10 test and
QFT-IT test results. Together these studies strongly suggest that
Table 4. Head-to-head comparison of the IP-10 test and the
QFT-IT for high risk (SS+) (kappa 0.62, agreement 83%).
QFT-IT
Neg. Pos. Indet. S
IP-10 test Neg. 8 3 2 13
Pos. 1 39 2 42
Indet. 2 0 2 4
S 11 42 2 59
doi:10.1371/journal.pone.0002858.t004
Table 5. Head-to-head comparison of the IP-10 test and the
QFT-IT for the low risk groups (SS2 and CC) (kappa 0.50,
agreement 72%).
QFT-IT
Neg. Pos. Indet. S
IP-10 test Neg. 30 0 3 33
Pos. 6 6 2 14
Indet. 6 0 8 14
S 42 6 13 61
doi:10.1371/journal.pone.0002858.t005
Figure 2. Association between exposure and test result. Proportions of children with positive, Quantiferon in tube test (QFT-IT), Tuberculin
Skin Test cut off 10 mm (TST), IP-10 test, and IL-2 test results by household exposure are shown. SS2: Children exposed to adults with smear negative
culture positive TB. Scanty (Sc), +, ++, +++ refer to the amount of acid fast bacteria seen in sputum smear microscopy. Indeterminate results are
included. Numbers above bars indicate n positive/n total for each smear group. For all biomarkers and TST there was a significant trend for increasing
test positivity rate by increasing smear grade among the TB contacts (p,0.0001).
doi:10.1371/journal.pone.0002858.g002
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unspecific chemokine release.
Nigeria has one of the highest TB rates in Africa. Therefore,
community exposure is high and the prevalence of infection is
anticipated to rise with age, hereby diluting the association with
other risk factors [6,30,36]. Interestingly, our study found that
among the low risk groups (the CC and SS2) there was a
significant trend towards an increase in positive responders with
increasing age for the IP-10, IL-2 and TST. This suggests that IP-
10 and IL-2 actually did identify children infected by community
exposure. We found no such trend in the high risk group which
could be due to the fact that the majority of the high risk children
were infected due to recent household exposure and not due
community exposure increasing with age. The association between
QFT-IT and increasing age was not significant, a result which
remains to be explained or confirmed
Both QFT-IT and IP-10 test had high degrees of indeterminate
responders (19/120, 16%, and 18/120, 15%, respectively). This
could be caused by either poor sample handling or de-facto
cellular anergy. A well described cause of inconclusive QFT-IT
test results is HIV infection and low CD4 cell count[14,16] and a
limitation of this study was that the HIV status and CD4 cell count
of the children were unknown and the number of families with
known HIV status was too small for statistical analysis. The high
degree of indeterminate responders underlines the importance of
including a marker for cellular anergy.
The levels of PHA induced IFN-c usually exceeds the levels of
antigen induced IFN-c. In the present study however, PHA
responses were remarkably low and could have contributed to the
high indeterminate rate. We do not think that this finding was due
to low age of the children or to handling of the samples because
there was no age-associated decrease in PHA and the responses to
the specific antigens were comparable to our previous study[17].
IL-2 was not induced by phytohaemaglutinin stimulation a
finding which has been reported by others[37]. Thus, it is not
possible to develop an IL-2 based test algorithm with an option of
indeterminate responses with the current set-up. Children with
indeterminate IL-2 test results would therefore be classified as
Figure 3. Association between age and test result. Proportions of community controls (CC) and sputum negative contacts(SS2) (n=61) with
positive, Quantiferon in tube test (QFT-IT), Tuberculin Skin Test (TST), IP-10 test, and IL-2 test result by age are shown. For IP-10 and QFT-IT,
indeterminate results are included. For all tests except the QFT-IT there was a significant trend for increasing test positivity rate by age. Numbers
above bars indicate the number of positive subjects per age group/n total for each group.
doi:10.1371/journal.pone.0002858.g003
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to the other tests. Still the IL-2 test had comparable performance
to QFT-IT and IP-10.
In thisandpreviousstudies (Ruhwaldet alsubmitted,[17])theIP-
10 test performed convincingly using whole blood stimulation and
determination of IP-10 using xMAP technology. xMAP however, is
not suitable for areas with limited resources. At present neither
QFT-IT nor an IP-10 test using xMAP are affordable technologies
for large scale screening of TB infection in low resource countries.
There is still a need for improving the technology towards a simple,
easy-to-use field friendly and cheap assay.
The present study had some limitation. First of all, the relative
small sample size may have influenced the result of the analysis of
association with age due to low numbers of children in each age
category. However, the overall excellent agreement between the
tests suggest that sample size was not too small for these
comparisons.
The study was performed in Nigeria and the samples were
transported to Denmark at a later stage which could have affected
the quality. However, we have done stability studies showing that
IP-10 and IL-2 are stable in plasma for at least 24 h at 20uC and
are not degraded in plasma after .5 repeated freeze thaw cycles
(unpublished).
Cut offs have been established using adult samples and it is
possible that alternative cut offs should be used for testing in
children. Our data does not suggest that age was a major problem
as the positivity rate among children at high risk was .70% in all
age groups and there was no age related difference in the mitogen-
response. Only in the low risk groups we found an association with
age which could be explained by increasing Mtb exposure with age
in a high endemic region.
In conclusion, we have shown that tests based on determination
of IP-10 and IL-2 perform with excellent concordance to the
QFT-IT test. IP-10 and IL-2 responses are strongly associated
with TB exposure as determined by exposure risk groups and by
grade of infectiousness of the index cases. In addition IP-10
response was associated with increasing age in the child with low
risk of infection.
We have provided data suggesting that IP-10 may serve as an
alternative and/or adjunct marker to IFN-c in the diagnosis of
active as well as latent TB infection and that IP-10 may improve
the overall diagnostic performance of the RD1 specific in vitro
tests. IL-2 holds similar properties but is released in low amounts
and there is no useful marker for anergy. As IP-10 is expressed in
high amounts, it holds promise for the development of a new
generation TB tests such as the lateral flow dipstick. Simpler and
cheap tests are needed to facilitate the management of TB by
increasing test accessibility and targeted preventive treatment
especially of infected HIV+ve patients and in children.
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Figure S1 Biomarker and Tuberculin Skin Test performance.
Antigen-dependent Interferon (IFN)-c, IFN-c-inducible protein
(IP)-10, and Interleukin (IL)-2, and the Tuberculin Skin Test
(TST) readings (in mm) were analysed by receiver operating
characteristic (ROC) curves. Result of ROC-curve analysis of the
diagnostic potential of antigen-dependent IFN-c, IL-2, and IP-10
and TST is shown. Community controls (CC) were used when
estimating specificity and contacts of sputum positive adults (SS+)
were used when estimating sensitivity. The cut offs with the highest
proportional diagnostic strength (or maximum Youdens Index,
sensitivity+specificity-1) were 635 pg/ml for IP-10, YI=0.56,
sensitivity 69%, Specificity 87%); 13 pg/ml for IL-2, YI=0.57,
sensitivity 75%, specificity 83%; 15 pg/ml for IFN-c, YI=0.65,
sensitivity 78%, Specificity 87%; and 6 mm for the TST,
YI=0.44, sensitivity 68%, specificity 76%.
Found at: doi:10.1371/journal.pone.0002858.s001 (2.21 MB TIF)
Methods S1 Diagnostic algorithms
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Table S1 Head-to-head comparison of Quantiferin in tube test
(QFT-IT), IP-10 test and IL-2 test
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(10 mm cut off), IP-10 test and IL-2 test
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